With 12,881 fresh cases, the coronavirus tally in India rose to 366,946 on Thursday, even as Prime Minister Narendra Modi ruled out the possibility of another round of lockdown, The Indian Express reported.
On Wednesday, Modi told states that “unlock, unlock, unlock” should be the way forward as they fight to control the pandemic and ramp up healthcare facilities.
Promising findings from the United Kingdom’s RECOVERY clinical trial have brought India’s anti-inflammatory steroid dexamethasone market under the spotlight.
While medical experts here are still studying the findings to understand how beneficial it may be as part of India’s treatment protocol for Covid-19 patients, industry executives expect global demand for the drug to shoot up like in the case of hydroxychloroquine earlier.
Globally, as many as 8,331,135 people have been infected while 448,504 have lost their lives.
